Diabetes & CV Disease
Sort by:
Devada Singh
Hypoglycemia Treatment: What Are the Benchmarks For Levels of Severity and What Are Their Treatment Options?
FEATURING
Cynthia Moreau
- 34 views
- May 13, 2021
KC Vascular Symposium 2022
Diabetic Foot Ulcer-Reconstructive Options
FEATURING
Dhaval Bhavsar
- 87 views
- May 12, 2022
Heart, Diabetes and Kidney: Make the Link
The New Data and Emerging Therapies Changing the HF Treatment Landscape
FEATURING
Petar Seferovic
- 100 views
- May 18, 2022
NutritionFacts.org
How May Plants Protect Against Diabetes?
FEATURING
Michael Greger
- 7 views
- October 3, 2017
Emory Diabetes Education Training Academy
Understanding Oral and Injectable Therapy Options for T2D Care
FEATURING
Sol Jacobs
- 113 views
- April 28, 2021
UChicago Medicine
Sleep Quality and Glycemic Variability in a Real-Life Setting in Adults with Type 2 Diabetes
FEATURING
Rachel Brandt
- 75 views
- June 3, 2022
ASCO 2022 Conference Coverage
Lecture Summary - ASCO 2022 on Characterization of Alpelisib-Associated Hyperglycemia in mBC
FEATURING
Sherry Shen
- 18 views
- June 8, 2022
Canadian Collaborative Research Network
Q&A: Colchicine, Oral GLP-1a and Other Drugs
- 86 views
- June 13, 2022
Emory Diabetes Education Training Academy
Evolution of SGLT2-Inhibitors and GLP1-RA's Relating to Macrovascular Outcomes
FEATURING
Francisco Pasquel
- 106 views
- April 26, 2021
Georgia Heart Institute
Buidling Cardiovascular Prevention Center
FEATURING
Laura Divoky,
Veerappan Ramesh Subramaniyam
- 17 views
- June 21, 2022
Emory Diabetes Education Training Academy
SGLT2-i Impact on Renal or HF Outcomes: What Is Observed in Non-Diabetic Patients?
FEATURING
Francisco Pasquel
- 264 views
- April 26, 2021
Houston Methodist DeBakey Heart and Vascular Center
Digital Health Management in Cardiovascular Diseases
FEATURING
Ahmed Soliman
- 46 views
- June 21, 2022